Start: October 25, 2021
End: January 31, 2025
This study will explore whether a behavioral treatment program for people with diabetes, called DREAM, can improve memory for African Americans with both poorly controlled diabetes and mild cognitive impairment (MCI). Participants will be randomly assigned to complete the DREAM program or a different home-based diabetes education. Over two years, all participants will have 11 in-home visits with a community health worker who will provide information on diabetes management. Participants in the DREAM program group will also receive four telehealth visits with a diabetes nurse educator. Every six months, all participants will complete memory tests, give blood, and undergo an eye exam. Researchers will use results from these tests to evaluate any changes in cognitive impairment and diabetes management.
Minimum Age: 65 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Thomas Jefferson University
Philadelphia, PA 19107
RecruitingRobin J Casten, PhD
Lead: Thomas Jefferson University
Source: ClinicalTrials.gov ID: NCT04259047